Works matching AU Dooley, Kelly E.

Results: 85
    1

    Clinical and diagnostic features of central nervous system tuberculosis in Indian children – a descriptive study.

    Published in:
    Therapeutic Advances in Infectious Disease, 2024, v. 11, p. 1, doi. 10.1177/20499361241274251
    By:
    • Daniel, Bella Devaleenal;
    • Selladurai, Elilarasi;
    • Balaji, Sarath;
    • Venkatesan, Arunagirinathan;
    • Venkatesan, Mythily;
    • Giridharan, Prathiksha;
    • Shanmugam, Sivakumar;
    • Natrajan, Saravanan;
    • Karunaianantham, Ramesh;
    • Kandasamy, Devika;
    • Subramani, Rajakumar;
    • Muthuramalingam, Kannan;
    • Pramila, Snegha K.;
    • Hissar, Syed;
    • Dooley, Kelly E.;
    • Thakur, Kiran T.
    Publication type:
    Article
    2
    3

    Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes.

    Published in:
    Emerging Infectious Diseases, 2025, v. 31, n. 3, p. 467, doi. 10.3201/eid3103.241634
    By:
    • Kurbatova, Ekaterina V.;
    • Whitworth, William C.;
    • Peddareddy, Lakshmi Praveena;
    • Phillips, Patrick P. J.;
    • Scott, Nigel A.;
    • Bryant, Kia E.;
    • Dawson, Rodney;
    • Wagner Cardoso, Sandra;
    • Samaneka, Wadzanai;
    • Engle, Melissa;
    • Waja, Ziyaad;
    • Sizemore, Erin;
    • Carr, Wendy;
    • Dooley, Kelly E.;
    • Savic, Radojka;
    • Swindells, Susan;
    • Chaisson, Richard E.;
    • Dorman, Susan E.;
    • Nahid, Payam;
    • Nhung V. Nguyen
    Publication type:
    Article
    4
    5
    6
    7
    8
    9

    Diabetes Mellitus and Tuberculosis Treatment Outcomes in Pune, India.

    Published in:
    Open Forum Infectious Diseases, 2021, v. 8, n. 4, p. 1, doi. 10.1093/ofid/ofab097
    By:
    • Mave, Vidya;
    • Gaikwad, Sanjay;
    • Barthwal, Madhusudan;
    • Chandanwale, Ajay;
    • Lokhande, Rahul;
    • Kadam, Dileep;
    • Dharmshale, Sujata;
    • Bharadwaj, Renu;
    • Kagal, Anju;
    • Pradhan, Neeta;
    • Deshmukh, Sona;
    • Atre, Sachin;
    • Sahasrabudhe, Tushar;
    • Meshram, Shailesh;
    • Kakrani, Arjun;
    • Kulkarni, Vandana;
    • Raskar, Swapnil;
    • Suryavanshi, Nishi;
    • Kornfeld, Hardy;
    • Dooley, Kelly E
    Publication type:
    Article
    10
    11
    12
    13
    14

    Designing Drug Trials: Considerations for Pregnant Women.

    Published in:
    Clinical Infectious Diseases, 2014, v. 59, n. suppl_7, p. S437, doi. 10.1093/cid/ciu709
    By:
    • Sheffield, Jeanne S.;
    • Siegel, David;
    • Mirochnick, Mark;
    • Heine, R. Phillips;
    • Nguyen, Christine;
    • Bergman, Kimberly L.;
    • Savic, Rada M.;
    • Long, Jill;
    • Dooley, Kelly E.;
    • Nesin, Mirjana
    Publication type:
    Article
    15

    Reply to Seddon, Schaaf, and Hesseling.

    Published in:
    2013
    By:
    • Dooley, Kelly E.;
    • Mitnick, Carole;
    • DeGroote, Mary Ann;
    • Obuku, Ekwaro;
    • Hamilton, Carol D.;
    • Makhene, Mamodikoe;
    • Shah, Sarita;
    • Brust, James C. M.;
    • Durakovic, Nadza;
    • Nuermberger, Eric
    Publication type:
    Letter
    16
    17
    18
    19

    Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.

    Published in:
    2015
    By:
    • Dorman, Susan E;
    • Savic, Radojka M;
    • Goldberg, Stefan;
    • Stout, Jason E;
    • Schluger, Neil;
    • Muzanyi, Grace;
    • Johnson, John L;
    • Nahid, Payam;
    • Hecker, Emily J;
    • Heilig, Charles M;
    • Bozeman, Lorna;
    • Feng, Pei-Jean I;
    • Moro, Ruth N;
    • MacKenzie, William;
    • Dooley, Kelly E;
    • Nuermberger, Eric L;
    • Vernon, Andrew;
    • Weiner, Marc;
    • Tuberculosis Trials Consortium
    Publication type:
    journal article
    20

    Daily Rifapentine for Treatment of Pulmonary Tuberculosis A Randomized, Dose-Ranging Trial.

    Published in:
    American Journal of Respiratory & Critical Care Medicine, 2015, v. 191, n. 3, p. 333, doi. 10.1164/rccm.201410-1843OC
    By:
    • Dorman, Susan E.;
    • Savic, Radojka M.;
    • Goldberg, Stefan;
    • Stout, Jason E.;
    • Schluger, Neil;
    • Muzanyi, Grace;
    • Johnson, John L.;
    • Nahid, Payam;
    • Hecker, Emily J.;
    • Heilig, Charles M.;
    • Bozeman, Lorna;
    • Pei-Jean I. Feng;
    • Moro, Ruth N.;
    • MacKenzie, William;
    • Dooley, Kelly E.;
    • Nuermberger, Eric L.;
    • Vernon, Andrew;
    • Weiner, Marc
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-53273-7
    By:
    • Chang, Vincent K.;
    • Imperial, Marjorie Z.;
    • Phillips, Patrick P. J.;
    • Velásquez, Gustavo E.;
    • Nahid, Payam;
    • Vernon, Andrew;
    • Kurbatova, Ekaterina V.;
    • Swindells, Susan;
    • Chaisson, Richard E.;
    • Dorman, Susan E.;
    • Johnson, John L.;
    • Weiner, Marc;
    • Sizemore, Erin E.;
    • Whitworth, William;
    • Carr, Wendy;
    • Bryant, Kia E.;
    • Burton, Deron;
    • Dooley, Kelly E.;
    • Engle, Melissa;
    • Nsubuga, Pheona
    Publication type:
    Article
    41

    Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical Trial.

    Published in:
    American Journal of Respiratory & Critical Care Medicine, 2024, v. 210, n. 11, p. 1358, doi. 10.1164/rccm.202401-0165OC
    By:
    • Xu, Ava Y.;
    • Velásquez, Gustavo E.;
    • Zhang, Nan;
    • Chang, Vincent K.;
    • Phillips, Patrick P. J.;
    • Nahid, Payam;
    • Dorman, Susan E.;
    • Kurbatova, Ekaterina V.;
    • Whitworth, William C.;
    • Sizemore, Erin;
    • Bryant, Kia;
    • Carr, Wendy;
    • Brown, Nicole E.;
    • Engle, Melissa L.;
    • Nhung, Nguyen Viet;
    • Nsubuga, Pheona;
    • Diacon, Andreas;
    • Dooley, Kelly E.;
    • Chaisson, Richard E.;
    • Swindells, Susan
    Publication type:
    Article
    42

    High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial.

    Published in:
    American Journal of Respiratory & Critical Care Medicine, 2024, v. 210, n. 3, p. 343, doi. 10.1164/rccm.202311-2004OC
    By:
    • Gausi, Kamunkhwala;
    • Ignatius, Elisa H.;
    • De Jager, Veronique;
    • Upton, Caryn;
    • Kim, Soyeon;
    • McKhann, Ashley;
    • Moran, Laura;
    • Wiesner, Lubbe;
    • von Groote-Bidlingmaier, Florian;
    • Marzinek, Philip;
    • Vanker, Naadira;
    • Yvetot, Joseph;
    • Pierre, Samuel;
    • Rosenkranz, Susan L.;
    • Swindells, Susan;
    • Diacon, Andreas H.;
    • Nuermberger, Eric L.;
    • Denti, Paolo;
    • Dooley, Kelly E.
    Publication type:
    Article
    43
    44
    45

    A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial.

    Published in:
    2021
    By:
    • Gausi, Kamunkhwala;
    • Ignatius, Elisa H.;
    • Xin Sun;
    • Soyeon Kim;
    • Moran, Laura;
    • Wiesner, Lubbe;
    • von Groote-Bidlingmaier, Florian;
    • Hafner, Richard;
    • Donahue, Kathleen;
    • Vanker, Naadira;
    • Rosenkranz, Susan L.;
    • Swindells, Susan;
    • Diacon, Andreas H.;
    • Nuermberger, Eric L.;
    • Dooley, Kelly E.;
    • Denti, Paolo;
    • Sun, Xin;
    • Kim, Soyeon
    Publication type:
    journal article
    46
    47
    48
    49
    50